Dimitrios Bafaloukos

7.0k total citations · 1 hit paper
132 papers, 4.5k citations indexed

About

Dimitrios Bafaloukos is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Dimitrios Bafaloukos has authored 132 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 34 papers in Cancer Research. Recurrent topics in Dimitrios Bafaloukos's work include Cancer Treatment and Pharmacology (35 papers), HER2/EGFR in Cancer Research (28 papers) and Breast Cancer Treatment Studies (26 papers). Dimitrios Bafaloukos is often cited by papers focused on Cancer Treatment and Pharmacology (35 papers), HER2/EGFR in Cancer Research (28 papers) and Breast Cancer Treatment Studies (26 papers). Dimitrios Bafaloukos collaborates with scholars based in Greece, United States and Germany. Dimitrios Bafaloukos's co-authors include P. Kosmidis, Helena Linardou, Samuel Murray, Issa J Dahabreh, George Fountzilas, Helen Gogas, Christos Papadimitriou, Dimitrios Pectasides, Gerasimos Aravantinos and Haralabos P. Kalofonos and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Dimitrios Bafaloukos

126 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer

2008 596 citations Helena Linardou, Issa J Dahabreh et al. profile →

Peers

Countries citing papers authored by Dimitrios Bafaloukos

Since Specialization

Citations

This map shows the geographic impact of Dimitrios Bafaloukos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitrios Bafaloukos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitrios Bafaloukos more than expected).

Fields of papers citing papers by Dimitrios Bafaloukos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitrios Bafaloukos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitrios Bafaloukos. The network helps show where Dimitrios Bafaloukos may publish in the future.

Co-authorship network of co-authors of Dimitrios Bafaloukos

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitrios Bafaloukos. A scholar is included among the top collaborators of Dimitrios Bafaloukos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitrios Bafaloukos. Dimitrios Bafaloukos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evolving Treatment Landscape of HER2-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond 2023 ·Cancers ·Ioannis Vathiotis, Dimitrios Bafaloukos, Konstantinos N. Syrigos, George Samonis	15
2	A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III) 2021 ·Cancers ·Victoria Atkinson, Pietro Quaglino, Massimo Aglietta, Michele Del Vecchio, Roberta Depenni, Francesca Consoli, Dimitrios Bafaloukos, Pier Francesco Ferrucci, (unknown), Ivana Krajsová, Paolo A. Ascierto, (unknown), Ana Arance, Helen Gogas, Hiya Banerjee, (unknown), (unknown), Bart Neyns	8
3	Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer 2021 ·Anticancer Research ·(unknown), Evangelia Razis, Georgia-Angeliki Koliou, (unknown), Eleftheria Tsolaki, Jeff Sperinde, Sofia Chrisafi, George Zarkavelis, (unknown), Anna Batistatou, Helen P. Kourea, Pavlos Papakostas, Dimitrios Bafaloukos, (unknown), (unknown), Αthanasios Kotsakis, Dimitrios Pectasides, Αngelos Koutras, Christos Christodoulou, George Fountzilas	6
4	Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy 2018 ·Cancer Medicine ·Marinos Tsiatas, Konstantine T. Kalogeras, Kyriaki Manousou, Ralph M. Wirtz, Helen Gogas, Elke Veltrup, Flora Zagouri, Georgios Lazaridis, Αngelos Koutras, Christos Christodoulou, George Pentheroudakis, Constantina Petraki, Dimitrios Bafaloukos, Dimitrios Pectasides, P. Kosmidis, Epaminontas Samantas, Charisios Karanikiotis, Pavlos Papakostas, Meletios Α. Dimopoulos, George Fountzilas	8
5	Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study 2015 ·Journal of Translational Medicine ·Αngelos Koutras, Konstantine T. Kalogeras, Ralph M. Wirtz, Zoi Alexopoulou, Mattheos Bobos, Flora Zagouri, Elke Veltrup, Eleni Timotheadou, Helen Gogas, George Pentheroudakis, (unknown), Christina Μagkou, Christos Christodoulou, Dimitrios Bafaloukos, Pavlos Papakostas, Gerasimos Aravantinos, Dimitrios Pectasides, Haralabos P. Kalofonos, George Fountzilas	12
6	Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial. 2015 ·PubMed ·Helena Linardou, Konstantine T. Kalogeras, Ralf Kronenwett, Zoi Alexopoulou, Ralph M. Wirtz, Flora Zagouri, Chrisoula D. Scopa, Helen Gogas, Kalliopi Petraki, Christos Christodoulou, Kitty Pavlakis, Αngelos Koutras, E. Samantas, (unknown), Dimitrios Pectasides, Dimitrios Bafaloukos, George Fountzilas	6
7	Differential Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer Subtypes 2014 ·PLoS ONE ·Giannis Mountzios, (unknown), Ioannis Kostopoulos, Helen P. Kourea, George Kouvatseas, Eleni Timotheadou, Pantelis Zebekakis, Ioannis Efstratiou, Helen Gogas, (unknown), Sofia Chrisafi, (unknown), George Pentheroudakis, Αngelos Koutras, Eleni Galani, Dimitrios Bafaloukos, George Fountzilas	15
8	Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial 2013 ·PLoS ONE ·George Fountzilas, Vassiliki Kotoula, Dimitrios Pectasides, George Kouvatseas, Eleni Timotheadou, Mattheos Bobos, (unknown), Christos Papadimitriou, Eleni Vrettou, (unknown), Αngelos Koutras, Evangelia Razis, Dimitrios Bafaloukos, Epaminontas Samantas, George Pentheroudakis, Dimosthenis Skarlos	11
9	Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer 2011 ·Breast Cancer Research and Treatment ·Evangelia Razis, Mattheos Bobos, Vassiliki Kotoula, Anastasia G Eleftheraki, Haralabos P. Kalofonos, Kitty Pavlakis, Pavlos Papakostas, Gerasimos Aravantinos, (unknown), Ioannis Efstratiou, Kalliopi Petraki, Dimitrios Bafaloukos, Ioannis Kostopoulos, Dimitrios Pectasides, Konstantine T. Kalogeras, Dimosthenis Skarlos, George Fountzilas	137
10	Somatic Mutations of the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitor Response to TKIs in Non-small Cell Lung Cancer: An Analytical Database 2008 ·Journal of Thoracic Oncology ·Samuel Murray, Issa J Dahabreh, Helena Linardou, Menelaos Manoloukos, Dimitrios Bafaloukos, P. Kosmidis	116
11	Prognostic Significance of Autoimmunity during Treatment of Melanoma with Interferon 2006 ·New England Journal of Medicine ·Helen Gogas, J. Ioannovich, Urania Dafni, (unknown), Konstantina Frangia, Dimosthenis Tsoutsos, P. Panagiotou, Aristidis Polyzos, O. Papadopoulos, Alexandros Stratigos, Christos Markopoulos, Dimitrios Bafaloukos, Dimitrios Pectasides, George Fountzilas, John M. Kirkwood	428
12	Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non–nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group 2006 ·Annals of Oncology ·George Fountzilas, Pavlos Papakostas, Urania Dafni, Thomas Makatsoris, M. Karina, Anna Kalogera‐Fountzila, N Maniadakis, Gerasimos Aravantinos, (unknown), Aristotelis Bamias, Christos Christodoulou, Theofanis Economopoulos, Haralabos P. Kalofonos, Angelos Nikolaou, Nikolaos Angouridakis, George P. Stathopoulos, Dimitrios Bafaloukos, Nicholas Pavlidis, J. Daniilidis	22
13	Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group 2005 ·Annals of Oncology ·Nikolaos I. Xiros, (unknown), Theofanis Economopoulos, G.F. Samelis, (unknown), Efstathios Kastritis, Haralabos P. Kalofonos, (unknown), D. Skarlos, Aristotelis Bamias, Helen Gogas, Dimitrios Bafaloukos, E. Samantas, P. Kosmidis	13
14	Adjuvant Cytotoxic and Endocrine Therapy in Pre- and Postmenopausal Patients With Breast Cancer and One to Nine Infiltrated Nodes 2004 ·American Journal of Clinical Oncology ·George Fountzilas, George P. Stathopoulos, George Kouvatseas, (unknown), G. Klouvas, E. Samantas, (unknown), (unknown), (unknown), (unknown), (unknown), Haralabos P. Kalofonos, Dimitrios Bafaloukos, V. Georgoulias, Evangelia Razis, (unknown), (unknown), P. Kosmidis, Dimosthenis Skarlos, Nicholas Pavlidis	1
15	Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) 2004 ·Anti-Cancer Drugs ·Jim Janinis, George P. Stathopoulos, Paul Nikolaidis, Haralabos P. Kalofonos, Anna Kalogera‐Fountzila, E. Samantas, Gerasimos Aravantinos, (unknown), (unknown), Thomas Makatsoris, S. Rigatos, Dimitrios Bafaloukos, Meletios Α. Dimopoulos, (unknown), George Fountzilas	6
16	Phase II study of docetaxel–vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer 2003 ·Annals of Oncology ·Gerasimos Aravantinos, Dimitrios Bafaloukos, George Fountzilas, Christos Christodoulou, Christos Papadimitriou, (unknown), Haralabos P. Kalofonos, Helen Gogas, P. Kosmidis, Meletios Α. Dimopoulos	26
17	Bone metastases from malignant melanoma: a retrospective review and analysis of 28 cases 2001 ·Radiology and Oncology ·Εlias Brountzos, Irene Panagiotou, Dimitrios Bafaloukos, Alexis Kelekis	12
18	A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study 1997 ·European Journal of Cancer ·Gerasimos Aravantinos, D. Skarlos, P. Kosmidis, A. Athanassiades, Dimitrios Bafaloukos, T. Giannakakis, (unknown), George Fountzilas	10
19	A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study 1997 ·Annals of Oncology ·George Fountzilas, A. Athanassiades, T. Giannakakis, Evangelos Briasoulis, Dimitrios Bafaloukos, Anna Kalogera‐Fountzila, (unknown), Haralabos P. Kalofonos, D. Pectasides, Eleni Andreopoulou, C. Bamia, P. Kosmidis, Nicholas Pavlidis, Dimosthenis Skarlos	28
20	Recombinant Interferon ALFA-2A in Combination With Carboplatin, Vinblastine, and Bleomycin in the Treatment of Advanced Malignant Melanoma 1996 ·American Journal of Clinical Oncology ·Dimitrios Bafaloukos, N. Pavlidis, (unknown), D. Skarlos, G. Klouvas, (unknown), T. Giannakakis, Νicolas Tsavaris, P. Kosmidis	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact